Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Eprosartan
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eprosartan 600mg tablets
0205052W0AAACAC
|
Eprosartan | Eprosartan | Cardiovascular System | 7,066 |
|
Eprosartan 300mg tablets
0205052W0AAAAAA
|
Eprosartan | Eprosartan | Cardiovascular System | 1,967 |
|
Teveten 600mg tablets
0205052W0BBACAC
|
Teveten | Eprosartan | Cardiovascular System | 662 |
|
Eprosartan 400mg tablets
0205052W0AAABAB
|
Eprosartan | Eprosartan | Cardiovascular System | 650 |
|
Teveten 300mg tablets
0205052W0BBAAAA
|
Teveten | Eprosartan | Cardiovascular System | 95 |
|
Eprosartan 300mg/5ml oral liquid
0205052W0AAADAD
|
Eprosartan | Eprosartan | Cardiovascular System | No data available |
|
Teveten 400mg tablets
0205052W0BBABAB
|
Teveten | Eprosartan | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.